
Bahar Alawi Craigo
Examiner (ID: 2673, Phone: (571)270-1326 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1699, 1759, 1673, 1623, 4131 |
| Total Applications | 905 |
| Issued Applications | 360 |
| Pending Applications | 129 |
| Abandoned Applications | 452 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10292238
[patent_doc_number] => 20150177238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'PROCESS FOR THE MANUFACTURING OF GLYCOCHIPS'
[patent_app_type] => utility
[patent_app_number] => 14/635164
[patent_app_country] => US
[patent_app_date] => 2015-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7313
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14635164
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/635164 | PROCESS FOR THE MANUFACTURING OF GLYCOCHIPS | Mar 1, 2015 | Abandoned |
Array
(
[id] => 10256370
[patent_doc_number] => 20150141367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'MODULATION OF GROWTH OF BIFIDOBACTERIA USING A COMBINATION OF OLIGOSACCHARIDES FOUND IN HUMAN MILK'
[patent_app_type] => utility
[patent_app_number] => 14/604951
[patent_app_country] => US
[patent_app_date] => 2015-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3178
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14604951
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/604951 | MODULATION OF GROWTH OF BIFIDOBACTERIA USING A COMBINATION OF OLIGOSACCHARIDES FOUND IN HUMAN MILK | Jan 25, 2015 | |
Array
(
[id] => 10267133
[patent_doc_number] => 20150152130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'TRANS-RESVERATROL POLYSACCHARIDE, METHOD FOR PRODUCING THE SAME, AND COMPOSITION COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/592702
[patent_app_country] => US
[patent_app_date] => 2015-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10561
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14592702
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/592702 | TRANS-RESVERATROL POLYSACCHARIDE, METHOD FOR PRODUCING THE SAME, AND COMPOSITION COMPRISING THE SAME | Jan 7, 2015 | Abandoned |
Array
(
[id] => 16443704
[patent_doc_number] => 10835608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Polymer-carbohydrate conjugates for drug delivery technology
[patent_app_type] => utility
[patent_app_number] => 14/561219
[patent_app_country] => US
[patent_app_date] => 2014-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 19916
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14561219
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/561219 | Polymer-carbohydrate conjugates for drug delivery technology | Dec 4, 2014 | Issued |
Array
(
[id] => 9858442
[patent_doc_number] => 20150038458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'Skin-Protecting Alkalinity-Controlling Composition and the Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/517792
[patent_app_country] => US
[patent_app_date] => 2014-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 16180
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14517792
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/517792 | Skin-Protecting Alkalinity-Controlling Composition and the Use Thereof | Oct 16, 2014 | Abandoned |
Array
(
[id] => 11066175
[patent_doc_number] => 20160263139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS'
[patent_app_type] => utility
[patent_app_number] => 15/028983
[patent_app_country] => US
[patent_app_date] => 2014-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 9433
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15028983
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/028983 | ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS | Oct 6, 2014 | Abandoned |
Array
(
[id] => 14454211
[patent_doc_number] => 10323057
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => Amphotericin B derivatives with improved therapeutic index
[patent_app_type] => utility
[patent_app_number] => 15/026520
[patent_app_country] => US
[patent_app_date] => 2014-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 40
[patent_no_of_words] => 16384
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026520
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/026520 | Amphotericin B derivatives with improved therapeutic index | Oct 5, 2014 | Issued |
Array
(
[id] => 10214878
[patent_doc_number] => 20150099870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-09
[patent_title] => 'Glycosylation Reactions Using Phenyl(trifluoroethyl)iodonium Salts'
[patent_app_type] => utility
[patent_app_number] => 14/505808
[patent_app_country] => US
[patent_app_date] => 2014-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7544
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14505808
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/505808 | Glycosylation reactions using phenyl(trifluoroethyl)iodonium salts | Oct 2, 2014 | Issued |
Array
(
[id] => 11210903
[patent_doc_number] => 09439920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-13
[patent_title] => 'Composition for the management of nausea and vomiting'
[patent_app_type] => utility
[patent_app_number] => 14/506387
[patent_app_country] => US
[patent_app_date] => 2014-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18567
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14506387
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/506387 | Composition for the management of nausea and vomiting | Oct 2, 2014 | Issued |
Array
(
[id] => 13251165
[patent_doc_number] => 10138262
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Reactive multi-functional additives for coatings compositions
[patent_app_type] => utility
[patent_app_number] => 14/486059
[patent_app_country] => US
[patent_app_date] => 2014-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4372
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486059
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/486059 | Reactive multi-functional additives for coatings compositions | Sep 14, 2014 | Issued |
Array
(
[id] => 17904321
[patent_doc_number] => 11458154
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Treatment of CYR61- and VEGF-mediated conditions
[patent_app_type] => utility
[patent_app_number] => 14/917098
[patent_app_country] => US
[patent_app_date] => 2014-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1523
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917098
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/917098 | Treatment of CYR61- and VEGF-mediated conditions | Sep 3, 2014 | Issued |
Array
(
[id] => 12322695
[patent_doc_number] => 09943540
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-17
[patent_title] => Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
[patent_app_type] => utility
[patent_app_number] => 14/476521
[patent_app_country] => US
[patent_app_date] => 2014-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2243
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14476521
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/476521 | Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid | Sep 2, 2014 | Issued |
Array
(
[id] => 14818515
[patent_doc_number] => 10406243
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Methods of treatment comprising a polyrotaxane and medicinal composition
[patent_app_type] => utility
[patent_app_number] => 14/913978
[patent_app_country] => US
[patent_app_date] => 2014-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 41
[patent_no_of_words] => 15693
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913978
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/913978 | Methods of treatment comprising a polyrotaxane and medicinal composition | Aug 17, 2014 | Issued |
Array
(
[id] => 10946938
[patent_doc_number] => 20140349959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'POLYSACCHARIDE GEL FORMULATION HAVING INCREASED LONGEVITY'
[patent_app_type] => utility
[patent_app_number] => 14/456779
[patent_app_country] => US
[patent_app_date] => 2014-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6222
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14456779
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/456779 | POLYSACCHARIDE GEL FORMULATION HAVING INCREASED LONGEVITY | Aug 10, 2014 | Abandoned |
Array
(
[id] => 16261231
[patent_doc_number] => 10752650
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-25
[patent_title] => Sophorolipid compound and composition comprising same
[patent_app_type] => utility
[patent_app_number] => 14/911174
[patent_app_country] => US
[patent_app_date] => 2014-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 18
[patent_no_of_words] => 12827
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911174
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/911174 | Sophorolipid compound and composition comprising same | Aug 5, 2014 | Issued |
Array
(
[id] => 9839545
[patent_doc_number] => 20150031628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'METHODS AND FORMULATIONS FOR CONVERTING INTRAVENOUS AND INJECTABLE DRUGS INTO ORAL DOSAGE FORMS'
[patent_app_type] => utility
[patent_app_number] => 14/452993
[patent_app_country] => US
[patent_app_date] => 2014-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6676
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14452993
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/452993 | METHODS AND FORMULATIONS FOR CONVERTING INTRAVENOUS AND INJECTABLE DRUGS INTO ORAL DOSAGE FORMS | Aug 5, 2014 | Abandoned |
Array
(
[id] => 9858419
[patent_doc_number] => 20150038436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'TAILORED GLYCOPOLYMERS AS ANTICOAGULANT HEPARIN MIMETICS'
[patent_app_type] => utility
[patent_app_number] => 14/450196
[patent_app_country] => US
[patent_app_date] => 2014-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 47134
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14450196
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/450196 | Tailored glycopolymers as anticoagulant heparin mimetics | Jul 31, 2014 | Issued |
Array
(
[id] => 14031263
[patent_doc_number] => 10227370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity
[patent_app_type] => utility
[patent_app_number] => 14/450192
[patent_app_country] => US
[patent_app_date] => 2014-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 38879
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14450192
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/450192 | Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity | Jul 31, 2014 | Issued |
Array
(
[id] => 9839560
[patent_doc_number] => 20150031643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME II'
[patent_app_type] => utility
[patent_app_number] => 14/340028
[patent_app_country] => US
[patent_app_date] => 2014-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5141
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14340028
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/340028 | COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME II | Jul 23, 2014 | Abandoned |
Array
(
[id] => 9839559
[patent_doc_number] => 20150031642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME I'
[patent_app_type] => utility
[patent_app_number] => 14/340016
[patent_app_country] => US
[patent_app_date] => 2014-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7759
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14340016
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/340016 | COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME I | Jul 23, 2014 | Abandoned |